Titan Pharmaceuticals, Inc. Fourth Quarter and Full Year 2012 Financial Results Registration Page

Titan Pharmaceuticals, Inc. Fourth Quarter and Full Year 2012 Financial Results
Monday, March 18, 2013 11:00 AM Eastern

To register for this event, please fill out and submit
the following form. All items with an * are required.

First Name*

Last Name*

Company*

Email Address*

Safe Harbor Statement

The press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the Company's development program and any other statements that are not historical facts. Such statements involve risks and uncertainties, including, but not limited to, those risks and uncertainties relating to difficulties or delays in development, testing, regulatory approval, production and marketing of the Company's drug candidates, adverse side effects or inadequate therapeutic efficacy of the Company's drug candidates that could slow or prevent product development or commercialization, the uncertainty of patent protection for the Company's intellectual property or trade secrets. Such statements are based on management's current expectations, but actual results may differ materially d ue to various factors, including those risks and uncertainties mentioned or referred to in this press release.

Yes, I have read and understand the Safe Harbor statement.

Click here to perform a System Check to determine if you can receive Streaming Media.
If you have problems listening, view our help pages, or click here to contact technical support.